What does Rohto Pharmaceutical do with its cash?

Cash conversion (operating CF ÷ operating income)

116.2%

Cash vs. profit gap

¥13.5B（純利益の 39.5%）

Shareholder returns

of net income 27.1% · of FCF 43.0%

Shareholder payments — dividends

of net income 27.1% · of FCF 43.0%

CapEx intensity (capex ÷ revenue)

7.6%

Investing CF relative to operating CF

62.3%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.